keyword
Keywords new research in medicine for g...

new research in medicine for gynaecological disease

https://read.qxmd.com/read/38412992/cellular-senescence-in-the-pathogenesis-of-ovarian-dysfunction
#1
JOURNAL ARTICLE
Miyuki Harada
The follicular microenvironment is crucial for normal ovarian function, and intra-ovarian factors, in coordination with gonadotropins, contribute to its regulation. Recent research has revealed that the accumulation of senescent cells worsens the adverse environment of various tissues and plays critical roles in chronological aging and various pathological conditions. Cellular senescence involves cell-cycle arrest, a senescence-associated secretory phenotype (SASP), macromolecular damage, and dysmetabolism...
February 27, 2024: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/38359733/do-probiotic-interventions-improve-female-unexplained-infertility-a-critical-commentary
#2
JOURNAL ARTICLE
Alessia Favaron, Engin Turkgeldi, Moe Elbadawi, Simon Gaisford, Abdul W Basit, Mine Orlu
Disruption of women's gut and cervicovaginal microbiota has been associated with multiple gynaecological diseases such as endometriosis, polycystic ovary syndrome, non-cyclic pelvic pain and infertility. Female infertility affects 12.6% of women worldwide; its aetiology is complex and multifactorial and can be underpinned by uterine pathologies, systemic diseases and age. In addition, a new perspective has emerged on the role of the gut and vaginal microbiomes in reproductive health. Research shows that the administration of precisely selected probiotics, often in combination with prior antibiotic treatment, may facilitate the restoration of symbiotic microbiota to increase successful conception and assisted reproductive technology outcomes...
November 20, 2023: Reproductive Biomedicine Online
https://read.qxmd.com/read/37650760/evaluation-of-follow-up-strategies-for-women-with-epithelial-ovarian-cancer-following-completion-of-primary-treatment
#3
REVIEW
Georgia Zachou, Fatima El-Khouly, James Dilley
BACKGROUND: This is an update of a previous Cochrane Review, last updated in 2014. Ovarian cancer is the eighth most common cancer and seventh most common cause of death due to cancer in women worldwide. Traditionally, most women who have been treated for cancer undergo long-term follow-up in secondary care. However, it has been suggested that the use of routine review may not be effective in improving survival, or health-related quality of life (HRQOL), or relieving anxiety. In addition, traditional follow-up may not be cost-effective...
August 31, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37317594/sik2-a-critical-glucolipid-metabolic-reprogramming-regulator-and-potential-target-in-ovarian-cancer
#4
REVIEW
Dan Hu, JunHong Du, YiJuan Xing, YueMei Cheng, RuiFen He, XiaoLei Liang, HongLi Li, YongXiu Yang
AIM: To explore the role of salt-inducible kinase 2 (SIK2) on glucose and lipid metabolism in ovarian cancer (OC), so as to increase the understanding of potential inhibitors targeting SIK2 and lay a foundation for future precision medicine in OC patients. METHODS: We reviewed and summarized the regulation effect of SIK2 on glycolysis, gluconeogenesis, lipid synthesis, and fatty acids β-oxidation (FAO) in OC, as well as the potential molecular mechanism and the prospects of potential inhibitors targeting SIK2 in future cancer treatments...
June 14, 2023: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/37253491/neoadjuvant-camrelizumab-plus-chemotherapy-for-locally-advanced-cervical-cancer-naci-study-a-study-protocol-of-a-prospective-single-arm-phase-ii-trial
#5
JOURNAL ARTICLE
Jing Chen, Yingyan Han, Yingjie Hu, Xue Feng, Xiaolin Meng, Shuaiqingying Guo, Chaoyang Sun, Gang Chen, Kezhen Li
INTRODUCTION: Neoadjuvant chemotherapy (NACT) is an emerging approach for locally advanced cervical cancer (LACC). However, the clinical response and postoperative adjuvant radiation or chemoradiation trimodality treatment resulted in controversy. PD-1 inhibitors have shown promising role in recurrent or metastatic cervical cancer, and there is preclinical evidence of the activation and synergistic effects of NACT on PD-1 inhibitors. This study aims to evaluate the efficacy and safety of the preoperative PD-1 inhibitor camrelizumab combined with NACT for LACC...
May 30, 2023: BMJ Open
https://read.qxmd.com/read/36920175/psychological-factors-increase-the-risk-of-ovarian-cancer
#6
REVIEW
Shuo Geng, Xu Zhang, Xiaoyu Zhu, Yadi Wang, Yingchen Wang, Yewu Sun
This study evaluated whether psychological stress increases the incidence of ovarian cancer. A literature search of the electronic databases PubMed and Web of Science from the date of inception to August 2022 was undertaken. Studies with data on psychosocial factors associated with ovarian cancer incidence were included in this study. A random-effect model meta-analysis was undertaken to estimate these data. We used subgroup analysis to adjust for heterogeneity. A total of 4 articles, 10 sets of data, 8 cohort studies, and 2 case-control studies from 682 records were included in this review...
December 2023: Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology
https://read.qxmd.com/read/36746607/new-concepts-on-the-etiology-of-endometriosis
#7
JOURNAL ARTICLE
Fiona L Cousins, Brett D McKinnon, Sally Mortlock, Harriet C Fitzgerald, Chenyu Zhang, Grant W Montgomery, Caroline E Gargett
Endometriosis is a serious, chronic disorder where endometrial tissue grows outside the uterus, causing severe pelvic pain and infertility. It affects 11% of women. Endometriosis is a multifactorial disorder of unclear etiology, although retrograde menstruation plays a major role. It has a genetic component with over 40 genetic risk factors mapped, although their mechanism of action is still emerging. New evidence suggests a role for retrograde menstruation of endometrial stem/progenitor cells, now that identifying markers of these cells are available...
February 6, 2023: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/36703286/the-story-of-freud-s-patient-anna-von-lieben-as-told-by-anna-von-lieben
#8
JOURNAL ARTICLE
Hilda Reilly
Anna von Lieben (Cäcilie M.) was treated for some 5 years by Sigmund Freud who discussed her case in Studies on Hysteria . This article presents an alternative view of the case based on the discovery of new primary material, principally, a handwritten corpus of confessional poetry by Anna herself. The poems were studied using a qualitative research methodology, interpretative phenomenological analysis (IPA), the findings of which were then further explored through the lens of her husband's unpublished diary entries...
March 2023: Journal of the Royal College of Physicians of Edinburgh
https://read.qxmd.com/read/36411490/preparation-of-triangular-silver-nanoparticles-and-their-biological-effects-in-the-treatment-of-ovarian-cancer
#9
JOURNAL ARTICLE
Man Yin, Xiangyu Xu, Hui Han, Jiahui Dai, Ronghe Sun, Linqing Yang, Junyu Xie, Yunfei Wang
BACKGROUND: In recent years, silver nanoparticles (AgNPs) have gradually been widely used, especially in the field of anticancer medicine. Ovarian cancer (OC) is the gynaecological malignancy with the highest mortality rate, and the current treatment is still based on surgery, chemotherapy and postoperative targeted therapy. Therefore, the development of safe and effective nanoparticles for targeted therapy of OC is very important. This study aimed to prepare a new type of triangular silver nanoparticles (tAgNPs) and evaluate the anticancer properties for OC in vitro and in vivo...
November 21, 2022: Journal of Ovarian Research
https://read.qxmd.com/read/36158077/cisplatin-for-cancer-therapy-and-overcoming-chemoresistance
#10
REVIEW
Ranmali Ranasinghe, Michael L Mathai, Anthony Zulli
Cisplatin spearheads the anticancer chemotherapeutics in present-day use although acute toxicity is its primary impediment factor. Among a plethora of experimental medications, a drug as effective or surpassing the benefits of cisplatin has not been discovered yet. Although Oxaliplatin is considered more superior to cisplatin, the former has been better for colorectal cancer while cisplatin is widely used for treating gynaecological cancers. Carcinoma imposes a heavy toll on mortality rates worldwide despite the novel treatment strategies and detection methods that have been introduced; nanomedicine combined with precision medicine, immunotherapy, volume-regulated anion channels, and fluorodeoxyglucose-positron emission tomography...
September 2022: Heliyon
https://read.qxmd.com/read/35994243/hysterectomy-with-radiotherapy-or-chemotherapy-or-both-for-women-with-locally-advanced-cervical-cancer
#11
REVIEW
Fani Kokka, Andrew Bryant, Adeola Olaitan, Elly Brockbank, Melanie Powell, David Oram
BACKGROUND: This is an update of the Cochrane Review published in Issue 4, 2015. Cervical cancer is one of the most frequent cause of death from gynaecological cancers worldwide. Many new cervical cancer cases in low-income countries present at an advanced stage. Standard care in Europe and the US for locally advanced cervical cancer (LACC) is chemoradiotherapy. In low-income countries, with limited access to radiotherapy, LACC may be treated with chemotherapy and hysterectomy. It is not certain if this improves survival...
August 22, 2022: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/35983674/the-figo-ovulatory-disorders-classification-system
#12
JOURNAL ARTICLE
Malcolm G Munro, Adam H Balen, SiHyun Cho, Hilary O D Critchley, Ivonne Díaz, Rui Ferriani, Laurie Henry, Edgar Mocanu, Zephne M van der Spuy
Ovulatory disorders are common causes of amenorrhea, abnormal uterine bleeding, and infertility, and are frequent manifestations of polycystic ovary syndrome (PCOS). There are many potential causes and contributors to ovulatory dysfunction that challenge clinicians, trainees, educators, and those who perform basic, translational, clinical, and epidemiological research. Similarly, therapeutic approaches to ovulatory dysfunction potentially involve a spectrum of lifestyle, psychological, medical, and procedural interventions...
October 2022: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/35762804/innovations-in-the-prevention-and-treatment-of-postpartum-hemorrhage-analysis-of-a-novel-medicines-development-pipeline-database
#13
JOURNAL ARTICLE
Annie R A McDougall, Maya Goldstein, Andrew Tuttle, Anne Ammerdorffer, Sara Rushwan, Roxanne Hastie, A Metin Gülmezoglu, Joshua P Vogel
BACKGROUND: A significant barrier to improving prevention and treatment of postpartum hemorrhage (PPH) is a lack of innovative medicines that meet the needs of women and providers, particularly those in low-and middle-income countries (LMICs). The Accelerating Innovation for Mothers (AIM) project established a new database of candidate medicines under development for five pregnancy-related conditions between 2000 and 2021. OBJECTIVE: To systematically identify and rank candidates for prevention and treatment of PPH...
June 2022: International Journal of Gynaecology and Obstetrics
https://read.qxmd.com/read/35613822/sintilimab-combined-with-bevacizumab-in-relapsed-persistent-ovarian-clear-cell-carcinoma-inova-an-investigator-initiated-multicentre-clinical-trial-a-study-protocol-of-clinical-trial
#14
JOURNAL ARTICLE
Ruyuan Li, Xingyu Liu, Chunyan Song, Wei Zhang, Jiahao Liu, Xiaofei Jiao, Yang Yu, Shaoqing Zeng, Jianhua Chi, Yingjun Zhao, Guanchen Ma, Yabing Huo, Ming Li, Zikun Peng, Guiling Li, Jie Jiang, Qing-Lei Gao
BACKGROUND: Ovarian clear cell carcinoma (OCCC) has an abysmal prognosis with a median overall survival (OS) of 25.3 months because of a low response to chemotherapy. The 5-year disease-specific survival rate after recurrence is 13.2%, with more than two-thirds of the patients dying within a year. Therefore, it is urgent to explore new therapeutic options for OCCC. Based on the characteristic immune-suppressive tumour microenvironment derived from the gene expression profile of OCCC, the combination of immunoantiangiogenesis therapy might have certain efficacy in recurrent/persistent OCCC...
May 24, 2022: BMJ Open
https://read.qxmd.com/read/35474372/a-survey-of-specialty-choice-among-obstetrics-and-gynecology-residents-in-japan-korea-and-taiwan
#15
JOURNAL ARTICLE
Ping-Lun Lin, Jian-Pei Huang, Tatsuya Fujii, Eun H Cho, Ming-Chao Huang
AIM: The percentage of medicine graduates opting for residency in obstetrics and gynecology (OB/GYN) has been decreasing in developed countries, including in Taiwan, Japan, and Korea. This multicountry study surveyed the OB/GYN residents affiliated with the Taiwan Association of Obstetrics and Gynecology (TAOG), the Japanese Society of Obstetrics and Gynecology (JSOG), and the Korean Society of Obstetrics and Gynecology (KSOG) to evaluate the factors affecting the choice of pursing OB/GYN...
July 2022: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/35403321/pseudo-pseudo-meig-s-syndrome-presenting-as-an-acute-surgical-abdomen-a-rare-entity-and-review-of-the-literature
#16
REVIEW
Ozan Karadeniz, Pinar Yalcın Bahat, Gizem Nur Koyan Karadeniz, İlteris Yaman, Rabia Merve Palalıoglu
AIM: Pseudo-pseudo Meigs' syndrome is a rare entity of systemic lupus erythematosus, which is defined with the combination of pleural effusion, elevated serum CA-125 levels, and ascites. It has similar clinical aspects with gynecological malignancies which may lead gynecologists to perform unnecessary surgeries and lab workouts. This review seeks to point out the importance of diagnosing pseudo-pseudo Meig's syndrome (PPMS) and endeavors to inform gynecologists about the differential diagnoses...
July 2022: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/35325897/viscum-album-l-therapy-in-oncology-an-update-on-current-evidence
#17
REVIEW
Anja Thronicke, Friedemann Schad, Marion Debus, Jan Grabowski, Georg Soldner
BACKGROUND: A majority of oncological patients apply add-on white-berry European mistletoe (Viscum album L., VA) extracts to reduce disease- and treatment-related symptoms and to improve health-related quality of life (HRQL). VA extracts exert various antitumor, pro-apoptotic, anti-proliferative, and immunomodulatory effects. Two current meta-analyses attribute life-prolonging and HRQL-improving properties to additive VA therapy. The aim of the present update was to review the current knowledge on VA extracts in clinical oncology...
2022: Complementary Medicine Research
https://read.qxmd.com/read/34549687/trends-gaps-and-future-directions-of-research-in-cervical-remodeling-during-pregnancy-a-bibliometric-analysis
#18
JOURNAL ARTICLE
Ourlad Alzeus G Tantengco, Joy Y Vink, Ramkumar Menon
PURPOSE: The cervix undergoes a dynamic remodeling process throughout pregnancy. Appropriate timing of cervical remodeling is essential in maintaining the fetus inside the uterus and ensuring cervical dilatation for safe delivery of the fetus at term. This study aims to determine the characteristics and trends of published articles in the field of cervical remodeling during pregnancy through a bibliometric analysis. MATERIALS AND METHODS: A systematic review of the literature on cervical remodeling during pregnancy was performed on using the Scopus database from inception to 2020...
September 22, 2021: Journal of Maternal-fetal & Neonatal Medicine
https://read.qxmd.com/read/33998107/genome-medicine-in-male-infertility-from-karyotyping-to-single-cell-analysis
#19
REVIEW
Koji Shiraishi
Male infertility is a multifactorial pathological condition that affects half of infertile couples. The majority of cases are categorized as idiopathic, especially in cases of nonobstructive azoospermia (NOA). An increasing number of genetic abnormalities have been shown to cause spermatogenic impairment with the development of microarray technologies and next-generation sequencing (NGS), moving beyond classical karyotype and polymerase chain reaction analyses of targeted genes. However, the majority of gene mutations, such as Klinefelter syndrome, azoospermia factor microdeletion, or congenital bilateral absence of the vas deferens, fail to function in a one gene-one phenotype manner...
August 2021: Journal of Obstetrics and Gynaecology Research
https://read.qxmd.com/read/33371080/guizhi-fuling-wan-for-chronic-pelvic-inflammatory-disease-protocol-a-protocol-for-systematic-review-and-meta-analysis
#20
JOURNAL ARTICLE
Chunrong Wang, Jingyun Chen, Yanling Xiao, Qilin Shen
BACKGROUND: Chronic pelvic inflammatory disease (CPID) is one of common diseases of department of gynaecology, point to female inside genital and circumferential organization to suffer from infection of all sorts of pathogenic bacteria and cause chronic inflammation sex disease, also cause one of main factors of infertile of female of childbearing age period. Due to its insidious onset, it is not easy to find out in the early stage. Therefore, it is difficult to obtain satisfactory curative effect by taking routine treatment with antibiotics...
December 18, 2020: Medicine (Baltimore)
keyword
keyword
89684
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.